Weldon Steven W 4
4 · GT Biopharma, Inc. · Filed Dec 18, 2020
Insider Transaction Report
Form 4
Weldon Steven W
DirectorCFO
Transactions
- Sale
Common Stock
2020-12-18$0.30/sh−50,000$15,000→ 3,903,700 total - Sale
Common Stock
2020-12-17$0.30/sh−50,000$15,000→ 4,003,700 total - Sale
Common Stock
2020-12-16$0.30/sh−50,000$15,000→ 4,053,700 total - Sale
Common Stock
2020-12-17$0.31/sh−50,000$15,500→ 3,953,700 total
Footnotes (1)
- [F1]. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020.